Insights
Search Results
Client Highlights
7.13.26
Wilson Sonsini Advises Oratomic on $300 Million Series A Financing
On July 7, 2026, Oratomic, a neutral atom quantum computing company focused on building the world’s first fault-tolerant quantum computers, announced that it raised $300 million in its Series A round co-led by ARCH Venture Partners, Spark Capital, and Khosla Ventures, alongside Bezos Expeditions, Index Ventures, General Catalyst, Lowercarbon Capital, Bain Capital, Formation, Nebular, David and Scott Aaronson, and others. Wilson Sonsini Goodrich & Rosati advised Oratomic on the transaction.
Client Highlights
7.09.26
Wilson Sonsini Advises Standard Bots on $200 Million Series C
On June 11, 2026, Standard Bots, the largest manufacturer of AI-native, industrial robotics in the United States, announced a $200 million Series C led by RoboStrategy and existing investors, valuing the company at $1 billion. Standard Bots is also expanding its manufacturing footprint in New York, increasing its ability to design, assemble, and deploy American-made robots at scale. Wilson Sonsini Goodrich & Rosati advised Standard Bots on the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises Arca on $64 Million Series A
On June 24, 2026, Arca Wealth (Arca), an AI-native wealth management company that brings personalized, advisor-led financial services, exited stealth and announced it secured $64 million across its seed round and Series A. The $48.5 million Series A was led by General Catalyst, with strong backing from Index Ventures and Venrock. Venrock also led the company's $15.5 million seed round. Wilson Sonsini Goodrich & Rosati advised Arca on the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises Monogram on $40 Million Seed Round as Company Emerges from Stealth
On July 7, 2026, Monogram, a developer of an artificial intelligence (AI) application built around visual interface, emerged from stealth and announced a $40 million seed round led by DST Global and Lux Capital. Wilson Sonsini Goodrich & Rosati advised Monogram on the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises TwelveLabs on $100 Million Series B
On July 1, 2026, TwelveLabs, a leading video intelligence company, announced it has raised $100 million in Series B funding. The round was co-led by NEA and NAVER Ventures with participation from Amazon, Radical Ventures, Korea Investment Partners, Index Ventures, Quadrille Capital, and Red Bull Ventures. Wilson Sonsini Goodrich & Rosati advised TwelveLabs on the transaction.
Podcasts
7.07.26
NextGen VC Podcast – Why the Future of Biotech Starts with the Brain
What does neuroscience have to do with venture capital? Quite a bit, according to Jason Pitts, Ph.D., principal at General Atlantic. In the latest episode of the NextGen VC Podcast, hosts and Wilson Sonsini partners Mike Hostetler and Jen Fang sit down with Jason to talk about the winding path that took him from studying the brain at Cornell University to evaluating some of the most promising companies in biotech.
Client Highlights
7.06.26
Wilson Sonsini Advises Hera on $27 Million Series A
On June 25, 2026, Hera, the company solving eldercare with human-centric AI, announced it has raised $27 million in Series A funding. The round was led by Bain Capital Ventures with continued participation from Accel. Wilson Sonsini Goodrich & Rosati advised Hera on the transaction.
Client Highlights
7.01.26
Wilson Sonsini Advises Kai Health on $4.8 Million Seed Round
On June 29, 2026, Kai Health, an AI-powered performance improvement platform for emergency medicine, announced a $4.8 million seed round led by Distributed Ventures. Wilson Sonsini Goodrich & Rosati advised Kai Health on the transaction.
Client Highlights
7.01.26
Wilson Sonsini Advises yes& on $3 Million Pre-Seed Financing
On June 23, 2026, yes&, a remix-native AI creative community platform, announced that it has raised $3 million in pre-seed funding, led by Accel with support from Parable. Wilson Sonsini Goodrich & Rosati advised yes& on the transaction.
Client Highlights
6.25.26
Wilson Sonsini Advises Sail Research on $80 Million Series A
On June 25, 2026, Sail Research, an infrastructure company purpose-built for long-horizon AI agents, announced it has raised $80 million in seed and Series A funding at a $450 million valuation. The Series A was led by Kleiner Perkins, and the seed round was led by Sequoia. Other participating investors included Redpoint Ventures, Theory Ventures, Vine Ventures, CRV, A*, and Abstract Ventures, in addition to angel investors, including John Hennessy, chairman of Alphabet Inc., Lip-Bu Tan, CEO of Intel, and Tri Dao, Chief Scientist at Together AI. Wilson Sonsini Goodrich & Rosati advised Sail Research on the transaction.
Client Highlights
6.24.26
Wilson Sonsini Advises Assort Health on $120 Million Series C
On June 24, 2026, Assort Health, the most widely used AI agents platform for the patient journey, announced a $120 million Series C led by Menlo Ventures at a valuation of $1.2 billion. Assort has now raised more than $222 million to become the standard for healthcare organizations wanting to transform the patient journey with AI. Wilson Sonsini Goodrich & Rosati advised Assort on the transaction.
In addition to Menlo Ventures, investors participating in the Series C financing include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.
What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare.
The Wilson Sonsini team that advised Assort on the financing included Lang Liu, Alex Youssef, Madisyn Klein, and Nara Jo.
For more information, please see Assort’s blog post.
In addition to Menlo Ventures, investors participating in the Series C financing include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.
What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare.
The Wilson Sonsini team that advised Assort on the financing included Lang Liu, Alex Youssef, Madisyn Klein, and Nara Jo.
For more information, please see Assort’s blog post.